Fresenius Kabi USA, LLC recalls Glycopyrrolate Injection, USP, 1 mg per 5 mL (0.2 mg per mL), 25 x 5 mL fill in a 6.5 mL vial, Rx only, Multiple Dose V
Recalled July 29, 2026 · FDA recall D-0725-2026 · Fresenius Kabi USA
Hazard
Presence of Particulate Matter: Hair was found in product · FDA Class II
Units
59,425 vials
Sold at
Nationwide within in the USA
Description
Presence of Particulate Matter: Hair was found in product
Product
Glycopyrrolate Injection, USP, 1 mg per 5 mL (0.2 mg per mL), 25 x 5 mL fill in a 6.5 mL vial, Rx only, Multiple Dose Vials, Fresenius Kabi, Lake Zurich, IL 60047 NDC Tray: 63323-578-05; NDC Vial: 63323-578-07
Manufacturer(s)
Fresenius Kabi USA, LLC
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →